Delivery Order SPE2DR25D2011-SPE2DR26FADRW
- Not listed
- The Defense Logistics Agency (DLA) awarded a $14,573.61 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, classified as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, was awarded on November 18, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.44 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,595.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, competitive delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $18,336.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 22, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $43,255.27 delivery order (Contract No. 4570044171) to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of November 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a $16,101.52 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication. This firm fixed-price, competitively awarded contract was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $5,709.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-set-aside competitive award reflects continued reliance on AmerisourceBergen's pharmaceutical distribution capabilities to support federal medical supply needs. The delivery order is set to conclude by November 6, 2025, with performance executed from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,845.11 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 3, 2025. This non-competitive delivery order represents a firm fixed price transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,017.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADRWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,636.47 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitive, firm fixed-price delivery order was issued on December 30, 2025, with a completion date of December 31, 2025. The award supports the DLA's medical supply chain operations and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle supplying a range of medications, vaccines, and medical devices to support military healthcare systems and the Defense Health Agency. As a major pharmaceutical distributor, AmerisourceBergen routinely fulfills federal procurement requirements through competitive awards, demonstrating capability in delivering specialty medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.6k | 12/29/25 |